Prellis Biologics
ID: 5304820Prellis Biologics is developing technology to build transplantable human organs and tissues.
6
Funding Rounds
$88.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Me***** Ma**** |
|
- | linkedin twitter |
| No**** Mu**** | - | - | linkedin twitter facebook |
Funding
Funding series
Funding Series Analysis
The company Prellis Biologics has raised a total of $58.2m in funding over 6 rounds.
Key Insights:
- Prellis Biologics Series C round, August 10, 2022: $35m
- Prellis Biologics Series B round, December 2021: $14.5m
- Prellis Biologics Series A round, July 2019: $8.7m
- Prellis Biologics funding round, September 2017: $1.8m
- Prellis Biologics funding round, August 2019: $8.7m
- Prellis Biologics, Inc funding round, July 2021: $19.25m
Industries
Prellis Biologics is active in the following industries: